Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Transluminal endoscopic step-up approach versus minimally invasive surgical step-up approach in patients with infected necrotising pancreatitis (TENSION trial): design and rationale of a randomised controlled multicenter trial [ISRCTN09186711].

van Brunschot S, van Grinsven J, Voermans RP, Bakker OJ, Besselink MG, Boermeester MA, Bollen TL, Bosscha K, Bouwense SA, Bruno MJ, Cappendijk VC, Consten EC, Dejong CH, Dijkgraaf MG, van Eijck CH, Erkelens GW, van Goor H, Hadithi M, Haveman JW, Hofker SH, Jansen JJ, Laméris JS, van Lienden KP, Manusama ER, Meijssen MA, Mulder CJ, Nieuwenhuis VB, Poley JW, de Ridder RJ, Rosman C, Schaapherder AF, Scheepers JJ, Schoon EJ, Seerden T, Spanier BW, Straathof JW, Timmer R, Venneman NG, Vleggaar FP, Witteman BJ, Gooszen HG, van Santvoort HC, Fockens P; Dutch Pancreatitis Study Group.

BMC Gastroenterol. 2013 Nov 25;13:161. doi: 10.1186/1471-230X-13-161.

PMID:
24274589
[PubMed - indexed for MEDLINE]
Free Article
2.

The Dutch surgical colorectal audit.

Van Leersum NJ, Snijders HS, Henneman D, Kolfschoten NE, Gooiker GA, ten Berge MG, Eddes EH, Wouters MW, Tollenaar RA; Dutch Surgical Colorectal Cancer Audit Group, Bemelman WA, van Dam RM, Elferink MA, Karsten TM, van Krieken JH, Lemmens VE, Rutten HJ, Manusama ER, van de Velde CJ, Meijerink WJ, Wiggers T, van der Harst E, Dekker JW, Boerma D.

Eur J Surg Oncol. 2013 Oct;39(10):1063-70. doi: 10.1016/j.ejso.2013.05.008. Epub 2013 Jul 18.

PMID:
23871573
[PubMed - indexed for MEDLINE]
3.

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.

Bökkerink GM, de Graaf EJ, Punt CJ, Nagtegaal ID, Rütten H, Nuyttens JJ, van Meerten E, Doornebosch PG, Tanis PJ, Derksen EJ, Dwarkasing RS, Marijnen CA, Cats A, Tollenaar RA, de Hingh IH, Rutten HJ, van der Schelling GP, Ten Tije AJ, Leijtens JW, Lammering G, Beets GL, Aufenacker TJ, Pronk A, Manusama ER, Hoff C, Bremers AJ, Verhoef C, de Wilt JH.

BMC Surg. 2011 Dec 15;11:34. doi: 10.1186/1471-2482-11-34.

PMID:
22171697
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome.

van Santvoort HC, Bakker OJ, Bollen TL, Besselink MG, Ahmed Ali U, Schrijver AM, Boermeester MA, van Goor H, Dejong CH, van Eijck CH, van Ramshorst B, Schaapherder AF, van der Harst E, Hofker S, Nieuwenhuijs VB, Brink MA, Kruyt PM, Manusama ER, van der Schelling GP, Karsten T, Hesselink EJ, van Laarhoven CJ, Rosman C, Bosscha K, de Wit RJ, Houdijk AP, Cuesta MA, Wahab PJ, Gooszen HG; Dutch Pancreatitis Study Group.

Gastroenterology. 2011 Oct;141(4):1254-63. doi: 10.1053/j.gastro.2011.06.073. Epub 2011 Jul 8.

PMID:
21741922
[PubMed - indexed for MEDLINE]
5.

Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial.

Bakker OJ, van Santvoort HC, van Brunschot S, Ahmed Ali U, Besselink MG, Boermeester MA, Bollen TL, Bosscha K, Brink MA, Dejong CH, van Geenen EJ, van Goor H, Heisterkamp J, Houdijk AP, Jansen JM, Karsten TM, Manusama ER, Nieuwenhuijs VB, van Ramshorst B, Schaapherder AF, van der Schelling GP, Spanier MB, Tan A, Vecht J, Weusten BL, Witteman BJ, Akkermans LM, Gooszen HG; Dutch Pancreatitis Study Group.

Trials. 2011 Mar 10;12:73. doi: 10.1186/1745-6215-12-73.

PMID:
21392395
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A step-up approach or open necrosectomy for necrotizing pancreatitis.

van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA, Dejong CH, van Goor H, Schaapherder AF, van Eijck CH, Bollen TL, van Ramshorst B, Nieuwenhuijs VB, Timmer R, Laméris JS, Kruyt PM, Manusama ER, van der Harst E, van der Schelling GP, Karsten T, Hesselink EJ, van Laarhoven CJ, Rosman C, Bosscha K, de Wit RJ, Houdijk AP, van Leeuwen MS, Buskens E, Gooszen HG; Dutch Pancreatitis Study Group.

N Engl J Med. 2010 Apr 22;362(16):1491-502. doi: 10.1056/NEJMoa0908821.

PMID:
20410514
[PubMed - indexed for MEDLINE]
Free Article
7.

Isolated limb perfusion for local gene delivery: efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas.

de Roos WK, de Wilt JH, van Der Kaaden ME, Manusama ER, de Vries MW, Bout A, ten Hagen TL, Valerio D, Eggermont AM.

Ann Surg. 2000 Dec;232(6):814-21.

PMID:
11088076
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions.

de Wilt JH, Manusama ER, van Etten B, van Tiel ST, Jorna AS, Seynhaeve AL, ten Hagen TL, Eggermont AM.

Br J Cancer. 2000 Nov;83(9):1176-82.

PMID:
11027431
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.

Bickels J, Manusama ER, Gutman M, Eggermont AM, Kollender Y, Abu-Abid S, Van Geel AN, Lev-Shlush D, Klausner JM, Meller I.

Eur J Surg Oncol. 1999 Oct;25(5):509-14.

PMID:
10527599
[PubMed - indexed for MEDLINE]
10.

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats.

de Wilt JH, Manusama ER, van Tiel ST, van Ijken MG, ten Hagen TL, Eggermont AM.

Br J Cancer. 1999 Apr;80(1-2):161-6.

PMID:
10389992
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Toxicity and antitumor activity of interferon gamma alone and in combinations with TNFalpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats.

Manusama ER, De Wilt JH, Ten Hagen TL, Marquet RL, Eggermont AM.

Oncol Rep. 1999 Jan-Feb;6(1):173-7.

PMID:
9864423
[PubMed - indexed for MEDLINE]
12.

Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats.

Manusama ER, Nooijen PT, Stavast J, de Wilt JH, Marquet RL, Eggermont AM.

J Surg Res. 1998 Aug;78(2):169-75.

PMID:
9733636
[PubMed - indexed for MEDLINE]
13.

Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program.

Manusama ER, Nooijen PT, Ten Hagen TL, Van Der Veen AH, De Vries MW, De Wilt JH, Van Ijken MG, Marquet RL, Eggermont AM.

Semin Surg Oncol. 1998 Apr-May;14(3):232-7.

PMID:
9548606
[PubMed - indexed for MEDLINE]
14.

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.

Nooijen PT, Manusama ER, Eggermont AM, Schalkwijk L, Stavast J, Marquet RL, de Waal RM, Ruiter DJ.

Br J Cancer. 1996 Dec;74(12):1908-15.

PMID:
8980389
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat.

Manusama ER, Nooijen PT, Stavast J, Durante NM, Marquet RL, Eggermont AM.

Br J Surg. 1996 Apr;83(4):551-5.

PMID:
8665257
[PubMed - indexed for MEDLINE]
16.

Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approach.

Manusama ER, Stavast J, Durante NM, Marquet RL, Eggermont AM.

Eur J Surg Oncol. 1996 Apr;22(2):152-7.

PMID:
8608832
[PubMed - indexed for MEDLINE]
17.

Regional application of TNF alpha in the treatment of cancer: a preclinical-clinical interactive program.

Eggermont AM, Manusama ER, ten Hagen TL.

J Inflamm. 1995-1996;47(1-2):104-13. Review.

PMID:
8913937
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk